{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:04:32Z","timestamp":1785517472010,"version":"3.56.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Commission","doi-asserted-by":"publisher","award":["JCYJ20220531092209021"],"award-info":[{"award-number":["JCYJ20220531092209021"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Commission","doi-asserted-by":"publisher","award":["ZDSYS20210623092000002"],"award-info":[{"award-number":["ZDSYS20210623092000002"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013050","name":"Guangdong Provincial Applied Science and Technology Research and Development Program","doi-asserted-by":"publisher","award":["2022B1515120034"],"award-info":[{"award-number":["2022B1515120034"]}],"id":[{"id":"10.13039\/501100013050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["ZDSYS20210623092000002"],"award-info":[{"award-number":["ZDSYS20210623092000002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174291"],"award-info":[{"award-number":["82174291"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jchromb.2026.125173","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:06:42Z","timestamp":1780531602000},"page":"125173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Shugan Xiaozhi decoction protects mice against metabolic dysfunction associated steatohepatitis by modulating liver injury and intestinal flora"],"prefix":"10.1016","volume":"1281","author":[{"given":"Shuai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangdong","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jchromb.2026.125173_bb0005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","article-title":"Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment","volume":"13","author":"Stefan","year":"2025","journal-title":"Lancet Diabetes Endo"},{"issue":"2024","key":"10.1016\/j.jchromb.2026.125173_bb0010","article-title":"Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases","volume":"12","author":"Sandireddy","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.jchromb.2026.125173_bb0015","article-title":"Research advances in the diagnosis and treatment of MASLD\/MASH","volume":"57","author":"Wang","year":"2025","journal-title":"Ann. Med."},{"issue":"7","key":"10.1016\/j.jchromb.2026.125173_bb0020","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/liv.15930","article-title":"The first MASH drug therapy on the horizon: current perspectives of resmetirom","volume":"44","author":"Petta","year":"2024","journal-title":"Liver Int."},{"key":"10.1016\/j.jchromb.2026.125173_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2025.02.033","article-title":"Integrative metabolism in MASLD and MASH: pathophysiology and emerging mechanisms","author":"Steinberg","year":"2025","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.jchromb.2026.125173_bb0030","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/fft2.292","article-title":"Nuciferine ameliorates high-fat diet-induced disorders of glucose and lipid metabolism in obese mice based on the gut\u2013liver axis","volume":"5","author":"Zhu","year":"2024","journal-title":"Food Front."},{"key":"10.1016\/j.jchromb.2026.125173_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.173458","article-title":"Polystyrene nanoplastics induce intestinal and hepatic inflammation through activation of NF-\u03baB\/NLRP3 pathways and related gut-liver axis in mice","volume":"935","author":"Chen","year":"2024","journal-title":"Sci. Total Environ."},{"issue":"2","key":"10.1016\/j.jchromb.2026.125173_bb0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/cells14020084","article-title":"Gut microbiome modulation in hepatocellular carcinoma: preventive role in NAFLD\/NASH progression and potential applications in immunotherapy-based strategies","volume":"14","author":"Monti","year":"2025","journal-title":"CELLS-BASEL."},{"issue":"1","key":"10.1016\/j.jchromb.2026.125173_bb0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13020-025-01116-y","article-title":"ZeXieYin formula alleviates atherosclerosis by regulating SBAs levels through the FXR\/FGF15 pathway and restoring intestinal barrier integrity","volume":"20","author":"Zhou","year":"2025","journal-title":"China Med. UK"},{"issue":"15","key":"10.1016\/j.jchromb.2026.125173_bb0050","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.3390\/molecules30153066","article-title":"Multifaceted interactions between bile acids, their receptors, and MASH: from molecular mechanisms to clinical therapeutics","volume":"30","author":"Tang","year":"2025","journal-title":"MOLECULES"},{"key":"10.1016\/j.jchromb.2026.125173_bb0055","article-title":"Gut microbiota modulation by traditional Chinese medicine: a translational strategy for metabolic dysfunction-associated steatotic liver disease","volume":"16","author":"Zhou","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jchromb.2026.125173_bb0060","doi-asserted-by":"crossref","unstructured":"Shu, X., Cao, Y., Wu, Y., Chen, M., Zhao, W., Ji, G., & Zhang, L. Gegen-Qinlian decoction alleviates metabolic dysfunction-associated steatohepatitis by modulating the microbiota-bile acid axis in mice. J. Ethnopharmacol. 347(2025)119719. https:\/\/doi-org\/https:\/\/doi.org\/10.1016\/j.jep.2025.119719.","DOI":"10.1016\/j.jep.2025.119719"},{"key":"10.1016\/j.jchromb.2026.125173_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.117841","article-title":"Chaihu guizhi ganjiang decoction attenuates nonalcoholic steatohepatitis by enhancing intestinal barrier integrity and ameliorating PPAR\u03b1 mediated lipotoxicity","volume":"326","author":"Wu","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jchromb.2026.125173_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2025.124784","article-title":"Quyu huazhuo decoction alleviates non-alcoholic steatohepatitis via remodeling the gut microbiota and regulating bile acid and short-chain fatty acid metabolism","author":"Lu","year":"2025","journal-title":"J. Chromatogr. B"},{"issue":"7","key":"10.1016\/j.jchromb.2026.125173_bb0075","first-page":"594","article-title":"Evaluating the clinical effect of modified Shugan Xiaozhi decoction in treating nonalcoholic fatly liver disease based on FibroScan technique","volume":"59","author":"Tang","year":"2018","journal-title":"J. Tradit. Chin. Med."},{"issue":"7","key":"10.1016\/j.jchromb.2026.125173_bb0080","first-page":"17","article-title":"Clinical study of Shugan Xiaozhi decoction combined with polyene phosphatidylcholine in treatment of 36 cases of nonalcoholic steatohepatitis","volume":"45","author":"Wei","year":"2013","journal-title":"Jiangsu. J. Tradit. Chin. Med"},{"key":"10.1016\/j.jchromb.2026.125173_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118127","article-title":"An herbal formulation \u201cShugan Xiaozhi decoction\u201d ameliorates methionine\/choline deficiency-induced nonalcoholic steatohepatitis through regulating inflammation and apoptosis-related pathways","volume":"329","author":"Wang","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jchromb.2026.125173_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156712","article-title":"Multi-approach analysis reveals the mechanism by which Shugan Xiaozhi decoction protects against metabolic dysfunction-associated steatohepatitis","volume":"141","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jchromb.2026.125173_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115831","article-title":"A classical herbal formula alleviates high-fat diet induced nonalcoholic steatohepatitis (NASH) via targeting mitophagy to rehabilitate dysfunctional mitochondria, validated by UPLC-HRMS identification combined with in vivo experiment","volume":"168","author":"Chen","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jchromb.2026.125173_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116617","article-title":"A high-dose of ursodeoxycholic acid treatment alleviates liver inflammation by remodeling gut microbiota and bile acid profile in a mouse model of non-alcoholic steatohepatitis","volume":"174","author":"Li","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.jchromb.2026.125173_bb0105","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"HEPATOLOGY"},{"key":"10.1016\/j.jchromb.2026.125173_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118147","article-title":"Paeonol attenuates nonalcoholic steatohepatitis by regulating intestinal flora and AhR\/NLRP3\/Caspase-1 metabolic pathway","volume":"329","author":"Yan","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"10","key":"10.1016\/j.jchromb.2026.125173_bb0115","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.str.2023.07.010","article-title":"Insights into substrate coordination and glycosyl transfer of poplar cellulose synthase-8","volume":"31","author":"Verma","year":"2023","journal-title":"STRUCTURE"},{"issue":"1","key":"10.1016\/j.jchromb.2026.125173_bb0120","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40104-023-00834-3","article-title":"Debranching enzymes decomposed corn arabinoxylan into xylooligosaccharides and achieved prebiotic regulation of gut microbiota in broiler chickens","volume":"14","author":"Wu","year":"2023","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"10.1016\/j.jchromb.2026.125173_bb0125","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ijbiomac.2022.09.100","article-title":"Comprehensive analysis of microbiome, metabolome and transcriptome revealed the mechanisms of Moringa oleifera polysaccharide on preventing ulcerative colitis","volume":"222","author":"Tian","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jchromb.2026.125173_bb0130","doi-asserted-by":"crossref","unstructured":"Li, C., Zhou, W., Li, M., Shu, X., Zhang, L., & Ji, G, Salvia-Nelumbinis naturalis extract protects mice against MCD diet-induced steatohepatitis via activation of colonic FXR-FGF15 pathway. Biomed. Pharmacother. 139 (2021)111587. https:\/\/doi. org\/https:\/\/doi.org\/10.1016\/j.biopha.2021.111587.","DOI":"10.1016\/j.biopha.2021.111587"},{"key":"10.1016\/j.jchromb.2026.125173_bb0135","article-title":"The role of intestinal flora in metabolic dysfunction-associated steatotic liver disease and treatment strategies","volume":"11","author":"Wang","year":"2025","journal-title":"Front Med (Lausanne)."},{"issue":"12","key":"10.1016\/j.jchromb.2026.125173_bb0140","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00535-024-02157-0","article-title":"Immunological dynamics in MASH: from landscape analysis to therapeutic intervention","volume":"59","author":"Rabiu","year":"2024","journal-title":"J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.jchromb.2026.125173_bb0145","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41575-024-00955-8","article-title":"A roadmap for clinical trials in MASH-related compensated cirrhosis","volume":"21","author":"Peric\u00e0s","year":"2024","journal-title":"Nat. Rev. Gastro Hepat"},{"key":"10.1016\/j.jchromb.2026.125173_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1066053","article-title":"Lingguizhugan decoction improves metabolic dysfunction associated steatohepatitis partially by modulating gut microbiota and correlated metabolites","volume":"13","author":"Zhu","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jchromb.2026.125173_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112896","article-title":"Qiang-Gan formula extract improves metabolic dysfunction associated steatohepatitis via regulating bile acid metabolism and gut microbiota in mice","volume":"258","author":"Li","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.jchromb.2026.125173_bb0160","doi-asserted-by":"crossref","first-page":"15203","DOI":"10.1038\/s41598-023-42358-w","article-title":"Honokiol affects the composition of gut microbiota and the metabolism of lipid and bile acid in methionine-choline deficiency dietinduced MASH mice","volume":"13","author":"Zhai","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2026.125173_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112825","article-title":"Jiangzhi granule attenuates metabolic dysfunction associated steatohepatitis through modulating bile acid in mice fed high-fat vitamin D deficiency diet","volume":"149","author":"Cao","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jchromb.2026.125173_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1106875","volume":"13","author":"Lv","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jchromb.2026.125173_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.120192","article-title":"Underlying mechanisms of traditional Chinese medicine in treating metabolic dysfunction-associated steatohepatitis: evidences from preclinical and clinical studies","author":"Wang","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jchromb.2026.125173_bb0180","article-title":"Bacteroides and NAFLD: pathophysiology and therapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jchromb.2026.125173_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117156","article-title":"Bacteroides ovatus alleviates high-fat and high-cholesterol-induced nonalcoholic fatty liver disease via gut-liver axis","volume":"178","author":"Sun","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.jchromb.2026.125173_bb0190","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12944-024-02391-8","article-title":"Effects of Bifidobacterium and rosuvastatin on metabolic-associated fatty liver disease via the gut\u2013liver axis","volume":"23","author":"Ran","year":"2024","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.jchromb.2026.125173_bb0195","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2302065","article-title":"Prophylactic treatment with Bacteroides uniformis and Bifidobacterium bifidum counteracts hepatic NK cell immune tolerance in nonalcoholic steatohepatitis induced by high fat diet","volume":"16","author":"Xu","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jchromb.2026.125173_bb0200","doi-asserted-by":"crossref","unstructured":"Li, N., Siddique, A., Liu, N., Teng, L., Ed-Dra, A., Yue, M., & Li, Y. Global Epidemiology and health risks of Bacillus cereus Infections: Special focus on infant foods. FOOD RES INT. 201(2025)115650. doi:https:\/\/doi.org\/10.1016\/j.foodres.2024.115650.","DOI":"10.1016\/j.foodres.2024.115650"},{"issue":"2","key":"10.1016\/j.jchromb.2026.125173_bb0205","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41564-018-0318-0","article-title":"A multicomponent toxin from Bacillus cereus incites inflammation and shapes host outcome via the NLRP3 inflammasome","volume":"4","author":"Mathur","year":"2019","journal-title":"Nat. Microbiol."},{"issue":"2","key":"10.1016\/j.jchromb.2026.125173_bb0210","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review","volume":"19","author":"Di Vincenzo","year":"2024","journal-title":"Intern. Emerg. Med."},{"issue":"12","key":"10.1016\/j.jchromb.2026.125173_bb0215","doi-asserted-by":"crossref","first-page":"6274","DOI":"10.1039\/D4FO00529E","article-title":"Intestinal absorption of bioactive oligopeptides: paracellular transport and tight junction modulation","volume":"15","author":"Yu","year":"2024","journal-title":"Food Funct."},{"issue":"3","key":"10.1016\/j.jchromb.2026.125173_bb0220","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5582\/bst.2024.01097","article-title":"Suppression of STK39 weakens the MASLD\/MASH process by protecting the intestinal barrier","volume":"18","author":"Xu","year":"2024","journal-title":"Biosci. Trends"},{"issue":"4","key":"10.1016\/j.jchromb.2026.125173_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.70155","article-title":"Farnesoid X receptor regulated Sepsis-induced abnormal bile acid metabolism via the fibroblast growth factor 15\/fibroblast growth factor receptor 4 pathway","volume":"13","author":"Zhou","year":"2025","journal-title":"Immun. Inflamm. Dis."},{"issue":"7","key":"10.1016\/j.jchromb.2026.125173_bb0230","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/metabo15070434","article-title":"Metabolomic alterations in patients with obesity and the impact of metabolic bariatric surgery: insights for future research","volume":"15","author":"Anastasiou","year":"2025","journal-title":"METABOLITES"},{"issue":"1","key":"10.1016\/j.jchromb.2026.125173_bb0235","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmet.2024.09.008","article-title":"Hepatic FXR-FGF4 is required for bile acid homeostasis via an FGFR4-LRH-1 signal node under cholestatic stress","volume":"37","author":"Song","year":"2025","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.jchromb.2026.125173_bb0240","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1038\/s41401-024-01329-1","article-title":"FXR activation remodels hepatic and intestinal transcriptional landscapes in metabolic dysfunction-associated steatohepatitis","volume":"45","author":"Wen","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jchromb.2026.125173_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1121203","article-title":"Effects of cholesterol-lowering probiotics on non-alcoholic fatty liver disease in FXR gene knockout mice","volume":"10","author":"Yang","year":"2023","journal-title":"Front. Nutr."},{"key":"10.1016\/j.jchromb.2026.125173_bb0250","doi-asserted-by":"crossref","unstructured":"D\u0105browska, A. M., & Dudka, J. Fexaramine as the intestine-specific farnesoid X receptor agonist: a promising agent to treat obesity and metabolic disorders. Drug Discov. Today (2025)104386. https:\/\/doi-org\/https:\/\/doi.org\/10.1016\/j.drudis.2025.104386.","DOI":"10.1016\/j.drudis.2025.104386"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322600262X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322600262X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:23:52Z","timestamp":1785515032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157002322600262X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"alternative-id":["S157002322600262X"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125173","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shugan Xiaozhi decoction protects mice against metabolic dysfunction associated steatohepatitis by modulating liver injury and intestinal flora","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125173"}}